ArticlePharmacoEconomics2025

Prognostic Testing for Prostate Cancer-A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice.

Adam Fridhammar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.